SLC2A1 and neoplasm: Transcription factor chimeric forkhead box M1- proteolysis targeting chimera (FOXM1-PROTAC) can also inhibit the expression of GLUT1, so the tumor cells lose the ability to metabolize glucose, achieving the purpose of the inhibition [42].